ovary, cell fate, disorders of sex development, sex reversal 20 21 22 A critical step that shapes the reproductive identity of the embryo is the sexual 37 differentiation of the bipotential gonads. Supporting cells in the fetal gonads are the first 38 cell population to differentiate, and dictate the fate of the gonads. As a consequence, 39 defects in supporting cell differentiation have dire consequences on reproductive 40 outcomes of the individual, from sex-reversal to infertility. Supporting cells differentiate 41 into either Sertoli cells, which drive testis development, or granulosa cells, which control 42 ovarian development. It has become clear that supporting cell differentiation, and 43 maintenance of their commitment, requires a coordinated action of multiple factors that 44 play either complementary, redundant and even antagonistic roles 1 . For instance, fate 45 decision and maintenance of ovarian identity relies mainly on two conserved elements: 46 the WNT4/RSPO1/beta-catenin pathway 2, 3, 4 and the transcription factor FOXL2 5, 6, 7 . 47
Abstract 23
Sex determination of the gonads begins with fate specification of gonadal supporting 24 cells into either ovarian granulosa cells or testicular Sertoli cells. This process of fate 25 specification hinges on a balance of transcriptional control. We discovered that 26 expression of the transcription factor RUNX1 is enriched in the fetal ovary in rainbow 27 trout, turtle, mouse, goat and human. In the mouse, RUNX1 marks the supporting cell 28 lineage and becomes granulosa cell-specific as the gonads differentiate. RUNX1 plays 29 complementary/redundant roles with FOXL2 to maintain fetal granulosa cell identity, 30
and combined loss of RUNX1 and FOXL2 results in masculinization of the fetal ovaries. 31
At the chromatin level, RUNX1 occupancy overlaps partially with FOXL2 occupancy in 32 the fetal ovary, suggesting that RUNX1 and FOXL2 target a common set of genes. 33
These findings identify RUNX1, with an ovary-biased pattern conserved across species, 34 as a novel regulator in securing the identity of ovarian supporting cells and the ovary. 35 36 These two elements synergistically promote expression of pro-ovarian genes and at the 48 same time, antagonize key pro-testis factors such as SOX9 and DMRT1. However, the 49 combined loss of these two key pro-ovarian signaling only results in an incomplete 50 inactivation of ovarian differentiation, suggesting that additional pro-ovarian factors are 51 at play during gonadal differentiation 8, 9 . Factors involved in gonad differentiation are 52 generally conserved in vertebrates and even invertebrates, although their position in the 53 hierarchy of the molecular cascade may change during evolution 10 . For instance, the 54 pro-ovarian transcription factor FOXL2 is important for ovarian differentiation/function in 55 human 11 , goat 12 and fish 13, 14 . The pro-testis transcription factor DMRT1 is highly 56 conserved and critical for testis development in worms, fly 15 , fish 16, 17 and mammals 18, 19, 57 20 . 58
Results 72
The pattern of Runx1 expression implies a potential role in fetal ovarian 73 differentiation 74
The runt gene, critical for ovarian differentiation in the fly 21 , has 3 orthologs in 75 mammals: RUNX1, RUNX2 and RUNX3. While all three RUNX transcription factors 76 bind the same DNA motif, they are known to have distinct, tissue-specific functions 26 . In 77 the mouse, Runx1 was the only one with a strong expression in the fetal ovary whereas 78
Runx2 and Runx3 were expressed weakly in the fetal gonads in a non-sexually 79 dimorphic way ( Fig. 1a) . At the onset of sex determination (Embryonic day or E11.5), 80
Runx1 expression was similar in both fetal testis and ovary before becoming ovary-81 specific after E12.5 (Fig. 1b) , consistent with observations by others 23 . An ovary-82 enriched expression of Runx1 during the window of early gonad differentiation was also 83 observed in other mammals such as human and goat, as well as in species belonging to 84 other classes of vertebrates such as the red-eared slider turtle and rainbow trout ( Fig.  85 1c-f), implying an evolutionarily conserved role of RUNX1 in ovary differentiation. 86
To identify the cell types that express Runx1 in the gonads, we examined a 87 reporter mouse model that produces EGFP under the control of Runx1 promoter 27 (Fig.  88 2). Consistent with the time-course of Runx1 mRNA expression ( Fig. 1b) , was present in both fetal ovary and testis at E11.5, and then increased in the ovary and 90 diminished in the testis at E12.5 onwards (Fig. 2) . At E11.5 in both testis and ovary, 91
Runx1-EGFP was present in a subset of SF1+/PECAM-somatic cell population 92 whereas absent in the SF1-/PECAM+ germ cells ( Fig. 2a-d ). In the testis, these Runx1-93 EGFP+ somatic cells corresponded to Sertoli cells, as demonstrated by a complete 94 overlap with SRY, the sex-determining factor that drives Sertoli cell differentiation 28 (Fig. 95 2e and S1). At this stage, there is no marker for ovarian supporting cells that allow us to 96 determine which subset of somatic cells were positive for Runx1-EGFP in the ovary. 97
However, at E12.5, when the sex of gonads becomes morphologically distinguishable, 98
Runx1-EGFP was specifically detected in the supporting cell lineage of both sexes: 99 strongly in FOXL2+ pre-granulosa cells of the ovary (Fig. 2g ), and weakly in SOX9+ 100
Sertoli cells of the testis (Fig. 2f and S1 ). Runx1-EGFP expression was eventually 101 turned off in the fetal testis while maintained in the ovary (Fig. 2h & i) . Throughout fetal 102 development of the ovary, Runx1-EGFP remained in FOXL2+ pre-granulosa cells ( Fig.  103 3). Runx1-EGFP was also detected in the ovarian surface epithelium at E16.5 and birth 104 (arrows in Fig. 3b -c), which gives rise to granulosa cells in the cortex of the ovary 29, 30 . 105
Runx1-EGFP was also expressed in somatic cells of the cortical region right underneath 106 the surface epithelium, and some of these Runx1-EGFP+ cells presented a weak 107 expression of FOXL2 ( Fig. 3g -i, arrowheads). In summary, Runx1 marks the supporting 108 cell lineage in the gonads at the onset of sex determination, and becomes granulosa 109 cell-specific as gonads differentiate. 110 111
Loss of Runx1 leads to ovarian transcriptomic changes resembling those of 112

Foxl2 knockout ovary 113
The pre-granulosa cell-specific pattern suggests that RUNX1, a factor involved in 114 cell lineage determination 25 , could contribute to granulosa cell differentiation and 115 ovarian development. To investigate its specific role in gonadal somatic cells and avoid 116 early embryonic lethality as a result of global deletion of Runx1 31, 32 , we generated a 117 conditional knockout mouse model, in which Runx1 was ablated in the SF1+ gonadal 118 somatic cells 33 (Fig. 4 ). While Runx1 expression was ablated successfully in the fetal 119 ovary ( Fig. 4a ), ovarian morphogenesis appeared normal at birth (Fig. 4b ). The 120 knockout (KO) ovary maintained its typical shape, with FOXL2+ pre-granulosa cells 121 scattered throughout the ovary and TRA98+ germ cells located mostly in the cortex (Fig.  122 4b). Despite its normal morphology, Runx1 KO newborn ovaries exhibited aberrant 123 transcriptomic profile: expression of 317 genes was altered significantly compared to 124 the control ( Fig. 4c ; Dataset S1). The transcriptomic changes of Runx1 KO ovary were 125 reminiscent of the ovary lacking Foxl2, a conserved gene involved in ovarian 126 differentiation/maintenance in vertebrates. In the mouse, loss of Foxl2 results in normal 127 ovarian morphogenesis at birth despite aberrant ovarian transcriptome 5 . When 128 comparing the genes changed significantly in the Runx1 KO (317 genes) with those 129 affected by the loss of Foxl2 (749 genes) in newborn ovary, we found that 41% of the 130 genes differentially expressed in Runx1 KO (129/317) were also misregulated in the 131 absence of Foxl2 (Fig. 4c ). The large majority of these 129 genes (93%; 120 genes) 132
were similarly changed by the loss of either Runx1 or Foxl2: 69% were downregulated 133 in both KOs (89 genes) and 24% were upregulated in both KOs (31 genes; Dataset S1). 134
One possible explanation for these common transcriptomic changes in Runx1 and Foxl2 135
KOs is that Runx1 could be part of the same signaling cascade as Foxl2. However, 136 analysis of Runx1 expression in Foxl2 KO newborn ovaries did not detect any changes 137 in Runx1 expression in the absence of Foxl2 (Fig. 4d Foxl2, . At E15.5, 148 differentiation of supporting cells into Sertoli cells in the testis or pre-granulosa cells in 149 the ovary has already been established. For instance, the transcription factor DMRT1, 150 which is involved in the maintenance of Sertoli cell identity 18 , is expressed in Sertoli 151 cells but not pre-granulosa cells (Fig. 5a & e) . At this stage, DMRT1 is also present in a 152 few germ cells in both testis and ovary 34 . Similar to the control ovaries, ovaries lacking 153 either Runx1 or Foxl2 had no DMRT1 proteins in the supporting cells ( Fig. 5a-c) . 154
However, the combined loss of Runx1 and Foxl2 resulted in aberrant expression of 155 DMRT1 in the supporting cells of the fetal ovary ( Fig. 5d ). At birth, Runx1/Foxl2 DKO 156 ovary formed structures similar to fetal testis cords in the center, with DMRT1+ cells 157 surrounding clusters of germ cells (Fig. 5i ). Such structure was not observed in Runx1 158 or Foxl2 single KO ovaries with the exception that DMRT1 protein started to appear in a 159 few supporting cells in the newborn Foxl2 KO ovaries, in what appears to be one of the 160 first signs of postnatal masculinization of Foxl2 KO ovaries at the protein level ( Fig. 5h) . of both Runx1 and Foxl2 (Fig. 7a ). Gene ontology (GO) analysis revealed that the downregulated genes were associated with "ovarian follicle development" and "female gonad development" whereas "male sex determination" was the most significantly 177 enriched process for the upregulated genes ( Fig. S4 ). To determine the contribution of 178
Runx1 and Foxl2 to the transcriptomic changes, the genes significantly downregulated 179 Fig. 7c ). In addition, some genes appeared to be controlled by both Foxl2 187
and Runx1, and were significantly downregulated (66 genes in the overlapping region 188 between the three circles in Fig. 7b ) or upregulated (29 genes in the overlapping region 189 between the three circles in Fig. 7c ) in all three knockouts. For instance, the genes Fst 190
and Cyp19a, both involved in granulosa cell differentiation/function 37, 38 , were 191 downregulated in Runx1 KO, Foxl2 KO, and more repressed in Runx1/Foxl2 DKO ( Fig.  192 7d). On the other hand, desert hedgehog (Dhh) was upregulated in all 3 knockouts, with 193 highest expression in the DKO (Fig. 7f ). Notably, 30% of the genes downregulated 194 between Runx1/Foxl2 DKO and Foxl2 KO ovaries, with 114 genes significantly 208 upregulated, and 104 genes significantly downregulated in the DKO (fold-change >1.5; 209 p<0.05; Fig. 7h and Dataset S5). Expression of most of these genes was already 210 altered in Foxl2 single KO ovaries; however, the additional loss of Runx1 exacerbated 211 their mis-expression. For instance, the pro-testis gene Dmrt1 and Nr5a1 were 212 significantly upregulated whereas the granulosa-cell enriched transcripts Fst and Ryr2 213 were further downregulated at birth ( Fig. 7d & i) . On the other hand, the additional loss 214 of Runx1 did not cause further upregulation of the Sertoli genes Sox9 and Amh at birth, 215
suggesting that Runx1 does not contribute to their repression in the ovary (Fig. 7j) . 216
Overall, the transcriptomic analyses of Runx1/Foxl2 single and double knockouts reveal 217 that the additional loss of Runx1 amplifies the mis-expression of genes already altered 218 by the sole loss of Foxl2. 219 220
RUNX1 shares genome-wide chromatin occupancy with FOXL2 in the fetal ovary 221
The masculinization of Runx1/Foxl2 DKO fetal ovaries and the transcriptomic 222 comparisons of Runx1/Foxl2 single and double KO ovaries suggest some interplay 223 between RUNX1 and FOXL2 to control granulosa cell identity. The fact that RUNX1 and 224
FOXL2 are both transcription factors raised the question whether this interplay could 225 occur at the chromatin level. We have previously identified the chromatin occupancy of 226 FOXL2 during ovarian differentiation by chromatin immunoprecipitation followed by 227 whole genome sequencing or ChIP-seq 41 . We performed additional de novo motif 228 analyses on the genomic regions bound by FOXL2 in the fetal ovary, and discovered 229 that several other DNA motifs were co-enriched with the FOXL2 DNA motif (Fig. 8a) . 230
Among them, RUNX DNA motif was the second most significantly co-enriched motif. 231
The other motifs were for CTCF, a factor involved in transcriptional regulation, enhancer 232 insulation and chromatin architecture 42 , and for the DNA motif recognized by multiple 233 members of the nuclear receptor family including liver receptor homolog-1 (LRH1 234 encoded by Nr5a2) and SF1 (encoded by Nr5a1), a known co-factor of FOXL2 43, 44 . 235 DNA motifs for TEAD transcription factors of the Hippo pathway, ETS, NFYA and 236 GATA4 were also significantly enriched. The enrichment of RUNX motif with FOXL2 237 binding motif suggests that RUNX1, the only RUNX enriched in pre-granulosa cells, 238 could bind similar genomic regions to FOXL2 in the fetal ovary. To confirm this 239 hypothesis, we performed ChIP-seq for RUNX1 in E14.5 ovaries (Dataset S6), the 240 same stage the FOXL2 ChIP-seq data were obtained 41 . The top de novo motif identified 241 in RUNX1 ChIP-seq (p<1e-559) matched the RUNX motif 45 (Fig. 8b) , and corresponded 242 to the motif that was co-enriched with FOXL2 in FOXL2 ChIP-seq ( Fig. 8a) . A total of 243 10,494 RUNX1 binding peaks were identified in the fetal ovary, with the majority of the 244 peaks located either in the gene body ( Fig. 8c ; 25% exon and 22% intron), or close 245 upstream of the transcription start site TSS (30% Promoter: <1kb of TSS; 12% 246
Upstream: -10 to -1kb of TSS). Comparison of genome-wide chromatin binding of 247 RUNX1 and FOXL2 in the fetal ovary revealed significant overlap: 54% (5,619/10,494) 248 of RUNX1 peaks overlapped with FOXL2 peaks (Fig. 8d ). 249
The transcriptomic data from Runx1/Foxl2 DKO ovaries provided us a list of 250 genes significantly changed as a result of the absence of Runx1, Foxl2, or both ( Fig. 7) . 251
To identify potential direct target genes of RUNX1 or/and FOXL2, we focused on the 252 918 genes differentially expressed in Runx1/Foxl2 DKO ovaries, and determined which 253 genes were nearest to RUNX1 or/and FOXL2 binding peaks ( Fig. 9a and Dataset S7). 254
More than 50% of these genes (492/918; Fig. 9a ) were the closest gene to RUNX1 255 or/and FOXL2 peak. Some of these genes were nearest to only FOXL2 peaks (116 256 genes in Fig. 9a ). For example, Pla2r1, a transcript enriched in pre-granulosa cells 39 257 and similarly downregulated in both Foxl2 KO and Runx1/Foxl2 DKO fetal ovaries ( Fig.  258 9b), contained two FOXL2-specific peaks, one in the promoter and one in the first 259 intron. On the other hand, 102 genes ( Fig. 9a ) had RUNX1 specific peaks near their 260 genomic locations. For instance, Ryr2, another transcript enriched in pre-granulosa 261 cells 39 , was strongly downregulated in both Runx1 KO and Runx1/Foxl2 DKO fetal and 262 newborn ovaries ( Fig. 7i and Fig. 9c ), and contained one RUNX1 specific peak in its 263 intronic region. Finally, 274 genes were the closest genes to peaks for both RUNX1 and 264 FOXL2, with the majority of them (197 genes) nearest to overlapping peaks for RUNX1 265 and FOXL2 (Fig. 9a ). Most of these genes (74%; 146/197 genes) were downregulated 266 in Runx1/Foxl2 DKO ovaries (Dataset S7). For instance, the granulosa cell enriched 267
genes Fst and Itpr2, both downregulated in Runx1/Foxl2 single and double KO ovaries 268 ( Fig. 7d and 9d ), contained common binding peaks for FOXL2 and RUNX1 ( Fig. 9a and 269 9d). For Fst, this binding of RUNX1 and FOXL2 was located in its first intron, in the 270 previously identified regulatory region that contributes to its expression 41, 46 . On the 271 other hand, the Sertoli cell gene Dmrt1, strongly upregulated in Runx1/Foxl2 DKO ( The molecular events that specify granulosa cell fate are complex and non-linear, 282
involving several signaling pathways that have redundant and complementary functions. 283 This is in contrast to the fetal testis, where the molecular pathway driving its 284 differentiation appears linear and sequential. Removal of one of the top pieces in the 285 testis differentiation pathway has a domino effect that prevents induction of downstream 286 events. This is exemplified by the complete gonadal sex-reversal in gain-or loss-of-287 function mouse models for SRY or SOX9, the two transcription factors responsible for 288 the initiation of the testis morphogenesis 28, 35, 47 . This is not the case in the mouse ovary, 289
where no single-gene loss/mutation results in a complete ovary-to-testis sex-reversal. 290
For instance, defects in the WNT4/RSPO1/beta-catenin or loss of Foxl2 causes a late or 291 postnatal partial ovary-to-testis sex-reversal, while the combined loss of Foxl2 and 292 elements of the WNT4/RSPO1/beta-catenin pathway (Wnt4 or Rspo1) leads to ovary-293 to-testis sex-reversal more pronounced than each single knockout model in the mouse 8, 294 9 . In this study, we demonstrated that Runx1 contributes to the molecular network 295 controlling pre-granulosa cell differentiation. Loss of Runx1 in somatic cells of the 296 ovaries altered ovarian transcriptome but did not affect ovarian morphogenesis at birth. 297
In contrast, the combined loss of Runx1 and Foxl2 compromised pre-granulosa cells 298 identity. Loss of Runx1 or Foxl2 affected a common set of genes, and these 299 transcriptomic changes were enhanced in the absence of both genes, reaching a 300 threshold that masculinized the fetal ovary. One of the most striking changes was the 301 expression of DMRT1 in the fetal supporting cells. DMRT1 is a key driver of Sertoli cell 302 differentiation and testis development in various species 15, 20 . In the fly, doublesex (dsx), 303 an ortholog of mammalian DMRT1, controls testis differentiation 15 . Intriguingly, runt, the 304 fly ortholog of RUNX1, drives ovarian differentiation by antagonizing the testis-specific 305 transcriptional regulation of dsx 21 . In the mouse, testis differentiation is not controlled by 306 DMRT1 but by SOX transcriptions factors SRY and its direct target SOX9. However, 307 RUNX1 does not appear to contribute to the repression of the key pro-testis gene Sox9 308 in the fetal ovary and SOX9 protein was not detected in Runx1/Foxl2 DKO ovary at 309 birth. This is in contrast with the phenotype of Wnt4/Foxl2 DKO newborn ovaries where 310 SOX9 was strongly upregulated, and as a consequence the ovaries were more 311 masculinized 9 . Overall, our findings suggest that slightly different pro-ovarian networks 312 control the repression of the evolutionary conserved pro-testis genes Sox9 and Dmrt1: 313 Sox9, which plays a primary role in Sertoli cell differentiation in the mouse, is repressed 314 by an interplay between the WNT4/RSPO1/beta-catenin and FOXL2 8, 9 . On the other 315 hand, Dmrt1, which has taken a secondary role in Sertoli cell differentiation in the 316 mouse, is repressed by an interplay between RUNX1 and FOXL2. 317 Seeking the mechanisms underlying the interplay between RUNX1 and FOXL2, 318
we identified that RUNX DNA binding motif is significantly co-enriched with FOXL2 motif 319 in genomic regions bound by FOXL2 in the fetal ovary. Moreover, RUNX1 genome-wide 320 occupancy partially overlaps with FOXL2 in the fetal ovary, suggesting that they bind 321 common regulatory regions to control granulosa-cell identity and ovarian development. precursor cells take when they are at the crossroad between cell proliferation/renewal 343 and lineage-specific commitment 25 . We discovered that Runx1 has an ovary-biased 344 expression during gonad differentiation in various vertebrate species, including turtle, 345 rainbow trout, goat, mouse, and human. In the mouse embryonic gonads, Runx1 is first 346 detected in the supporting cells in a non-sexually dimorphic way at the onset of sex 347 determination. While its expression is maintained in the ovary, Runx1 appears to be 348 actively repressed in the testis between E11.5 and E12.5 as the supporting cells commit 349
to Sertoli cell fate. The suppression of Runx1 in the fetal testis is corroborated by In contrary to the testis, the fetal ovary maintains expression of Runx1 in the 363 supporting cells as they differentiate into granulosa cells. During ovarian differentiation, 364 granulosa cells arise from two different waves at different stages of development: the 365 first cohort of granulosa cells arises from the bipotential supporting cell precursors that 366 are able to differentiate into either Sertoli cells or pre-granulosa cells during sex 367 determination 55 . The second wave of granulosa cells that eventually populate the 368 cortical region of the ovary appears later in gestation. These cells of the second wave 369 arise from LGR5+ cells of the ovarian surface epithelium that ingress into the ovary from 370 E15.5 to postnatal day 4 and eventually become LGR5-/FOXL2+ granulosa cells 29, 30, 371 56 . This timing of the establishment of the second cohort of granulosa cells correlates 372 with the expression of Runx1-EGFP in a subset of cells in the surface epithelium and in 373 granulosa cells of the ovarian cortex at E16.5 and birth. These results suggest that 374
Runx1 marks granulosa cell precursors that will give rise to the second wave of FOXL2+ 375 granulosa cells in the cortex. Therefore, both expression at onset of sex determination 376 and at the surface epithelium/cortex at the time of the second wave of granulosa cells 377 recruitment suggest that Runx1 is activated in cells that are primed to become 378 supporting/granulosa cells. However, the potential involvement of the hippo pathway in granulosa cell differentiation 404 has not been investigated. 405
In conclusion, we identified RUNX1 as a transcription factor involved in pre-406 granulosa cell differentiation. RUNX1 delineates the supporting cell lineage and 407 contributes to granulosa cell differentiation and maintenance of their identity through an 408 interplay with FOXL2. Our findings provide new insights into the genomic control of 409 granulosa cell differentiation, and pave the way for the identification of novel 410 transcription factors and cis-signatures contributing to the fate determination of 411 granulosa cells and the consequent formation of a functional ovary.
Methods 413
Mouse models 414
Tg(Runx1-EGFP) reporter mouse was purchased from MMRRC (MMRRC_010771-415 UCD), and CD-1 mice were purchased from Charles River (stock number 022). Runx1 +/-416 (B6.129S-Runx1 tm1Spe /J) and Runx1 f/f (B6.129P2-Runx1 tm1Tani /J) mice were purchased 417 from the Jackson Laboratory (stock numbers 005669 and 008772, respectively). For the Tg(Runx1-EGFP) mice, gonads were collected and fixed in 4% 436 paraformaldehyde for 1-2h at room temperature. Immunofluorescence experiments 437 were performed on whole gonads at E11.5 and E12.5 and on 8 μm cryosections for 438 E14.5, E16.5 and P0 (birth) gonads. The EGFP was detected in wholemount gonads by 439 direct fluorescent imaging, and an anti-GFP antibody was used for 440 immunofluorescences on sections. For the different knockout models, gonads were 441 fixed in 4% paraformaldehyde overnight at 4°C. Immunofluorescence experiments were 442 performed on 7 μm paraffin sections of E15.5 and P0 gonads as previously described 60 . 443
The antibodies used in this study are listed in Table S1 . Whole gonads and sections 444
were imaged under a Leica DMI4000 confocal microscope. 445 446
Real-Time PCR analysis in the mouse 447
For the time-course kinetics of Runx1 expression, fetal gonads from CD-1 embryos at 448 embryonic day E11.5, E12.5, E13.5, E14.5, E16.5, E18.5 and postnatal day P3 were 449 separated from the mesonephros and snap-frozen. For each stage, 3 biological 450 replicates were collected, with 6 gonads/replicate for the E11.5 stage and 3 451 gonads/replicate for the other stages. For Runx1 KO analysis, control and KO ovaries 452 were collected at E14.5 (n = 4 biological replicates/genotype 
Runx1 expression in other species 466
For the rainbow trout, Runx1 expression during gonadal development was assessed by 467 quantitative PCR, as previously described 61 . Species-specific primers used are listed in 468 Stain Kit and user manual following protocol FS450-0004. Arrays were scanned in an 497
Affymetrix Scanner 3000 and data was obtained using the GeneChip® Command 498 Console Software (AGCC; Version 3.2) and Expression Console (Version 1.2). 499
Microarray data have been deposited in GEO under accession code GSE129038. Gene 500 expression analyses were conducted with Partek software (St. Louis, Missouri) using a 501 one-way ANOVA comparing the RMA normalized log2 intensities. A full dataset Excel 502 file containing the normalized log2 intensity of all genes for each genotype, and a 503 graphic view of their expression is provided in Dataset S2. In order to identify 504 differentially expressed genes, analysis of variance (ANOVA) was used to determine if 505 there was a statistical difference between the means of groups and the gene lists were 506 filtered with p<0.05 and fold-change cutoff of 1.5. The heat-map was created comparing 507 the genes that were significantly different between control and Runx1/Foxl2 double 508 knockout ovaries. Venn diagrams were generated in Partek by comparing gene-509 symbols between the lists of genes differentially expressed. 510 511
ChIP-seq assays and analysis 512
Ovaries from E14.5 CD-1 embryos were separated from the mesonephros, snap-frozen, 513
and stored at -80°C. RUNX1 ChIP-seq experiments and analyses in E14.5 ovaries were 514 performed as previously described for FOXL2 ChIP-seq 41 .Two independent ChIP-seq 515 experiments were performed by Active Motif Inc. using 20-30 μg of sheared chromatin 516 from pooled embryonic ovaries (n=100-120 ovaries/ChIP), and 10 μl of RUNX1 517 antibody 64 (provided by Drs. Yoram Groner and Ditsa Levanon, the Weizmann Institute 518 of Science, Israel). ChIP-seq libraries were sequenced as single-end 75-mers by 519
Illumina NextSeq 500, then filtered to retain only reads with average base quality score 520 >20. Reads were mapped against the mouse mm10 reference genome using Bowtie 65 521 v1.2 with parameter "-m 1" to collect only uniquely-mapped hits. Duplicate mapped 522 reads were removed using Picard tools MarkDuplicates.jar (v1.110). The number of 523 uniquely-mapped non-duplicate reads for each biological replicate was 8,932,674 and 524 15,036,698. After merging the replicate datasets, binding regions were identified by 525 peak calling using HOMER v.4.9 66 with FDR<1e-5. Called peaks were subsequently re-526 defined as 300mers centered on the called peak midpoints and filtered for a 4-fold 527 enrichment over input and over local signal. Genomic distribution of RUNX1-bound 528 regions was determined based on Refseq gene models as downloaded from the UCSC 529 Genome Browser as of August 09, 2017. Enriched motifs were identified using HOMER 530 findMotifsGenome.pl de novo motif analysis with parameter "-size given". For RUNX1 531 and FOXL2 ChIP-seq comparisons, binding peaks that had at least 1 bp in common 532 were considered overlapping. Peaks were assigned to the nearest gene based on 533
RefSeq. Gene lists were analyzed for enrichment using the online tool EnrichR 67 . The 534
ChIP-seq data are available in the ReproGenomics Viewer (https://rgv.genouest.org) 68, 535 69 and Gene Expression Omnibus (GSE128767; http://www.ncbi.nlm.nih.gov/geo/). 
